Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.500
0.00 (0.00%)
Apr 24, 2025, 5:24 PM IDT

Can-Fite BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
0.670.740.810.850.76
Upgrade
Revenue Growth (YoY)
-9.29%-8.27%-5.04%11.80%-62.45%
Upgrade
Gross Profit
0.670.740.810.850.76
Upgrade
Selling, General & Admin
3.052.963.143.852.95
Upgrade
Research & Development
5.765.987.769.8511.95
Upgrade
Operating Expenses
8.88.9410.9113.714.9
Upgrade
Operating Income
-8.13-8.2-10.1-12.84-14.14
Upgrade
Interest Expense
-----0.36
Upgrade
Interest & Investment Income
0.290.510.220.020.04
Upgrade
Currency Exchange Gain (Loss)
-0.010.06-0.050.060.03
Upgrade
Other Non Operating Income (Expenses)
-0.01-0.01-0.02-0.02-0.02
Upgrade
EBT Excluding Unusual Items
-7.87-7.65-9.94-12.78-14.45
Upgrade
Gain (Loss) on Sale of Investments
-0.010.01-0.230.160.01
Upgrade
Pretax Income
-7.88-7.63-10.17-12.62-14.44
Upgrade
Earnings From Continuing Operations
-7.88-7.63-10.17-12.62-14.44
Upgrade
Net Income
-7.88-7.63-10.17-12.62-14.44
Upgrade
Preferred Dividends & Other Adjustments
---2.590.72
Upgrade
Net Income to Common
-7.88-7.63-10.17-15.21-15.16
Upgrade
Shares Outstanding (Basic)
2,1761,278816553358
Upgrade
Shares Outstanding (Diluted)
2,1761,278816553358
Upgrade
Shares Change (YoY)
70.22%56.71%47.49%54.31%317.19%
Upgrade
EPS (Basic)
-0.00-0.01-0.01-0.03-0.04
Upgrade
EPS (Diluted)
-0.00-0.01-0.01-0.03-0.04
Upgrade
Free Cash Flow
-7.64-8.44-10.81-9.87-12.09
Upgrade
Free Cash Flow Per Share
-0.00-0.01-0.01-0.02-0.03
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-1206.23%-1102.96%-1246.42%-1505.51%-1853.08%
Upgrade
Profit Margin
-1169.14%-1027.46%-1255.93%-1782.53%-1986.63%
Upgrade
Free Cash Flow Margin
-1133.83%-1136.20%-1334.57%-1156.98%-1584.40%
Upgrade
EBITDA
-8.12-8.18-10.08-12.83-14.13
Upgrade
D&A For EBITDA
0.010.020.010.010.01
Upgrade
EBIT
-8.13-8.2-10.1-12.84-14.14
Upgrade
Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.